25.04.2013 | E Xu; J Zhang; X Chen, Oncogene, 2013

MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability Oncogene 32, 2169 (25 April 2013). doi:10.1038/onc.2012.238 Authors: E Xu, J Zhang & X Chen

mehr

25.04.2013 | S M Jafarnejad; G S Ardekani; M Ghaffari; M Martinka; G Li, Oncogene, 2013

Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion Oncogene 32, 2131 (25 April 2013). doi:10.1038/onc.2012.239 Authors: S M Jafarnejad, G S Ardekani, M Ghaffari, M Martinka & G Li

mehr

28.02.2013 | A Ward; A Balwierz; J D Zhang; M Küblbeck; Y Pawitan; T Hielscher; S Wiemann; Ö Sahin, Oncogene, 2013

Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer Oncogene 32, 1173 (28 February 2013). doi:10.1038/onc.2012.128 Authors: A Ward, A Balwierz, J D Zhang, M Küblbeck, Y Pawitan, T Hielscher, S ...

mehr

21.02.2013 | J-C Cheng; H-M Chang; P C K Leung, Oncogene, 2013

Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells Oncogene 32, 1041 (21 February 2013). doi:10.1038/onc.2012.127 Authors: J-C Cheng, H-M Chang & P C K Leung

mehr

21.02.2013 | J Xu; Y Li; F Wang; X Wang; B Cheng; F Ye; X Xie; C Zhou; W Lu, Oncogene, 2013

Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer Oncogene 32, 976 (21 February 2013). doi:10.1038/onc.2012.121 Authors: J Xu, Y Li, F Wang, X Wang, B Cheng, F Ye, X Xie, C Zhou & W Lu

mehr

07.02.2013 | A Peschiaroli; A Giacobbe; A Formosa; E K Markert; L Bongiorno-Borbone; A J Levine; E Candi; A D'Alessandro; L Zolla ..., Oncogene, 2013

miR-143 regulates hexokinase 2 expression in cancer cells Oncogene 32, 797 (7 February 2013). doi:10.1038/onc.2012.100 Authors: A Peschiaroli, A Giacobbe, A Formosa, E K Markert, L Bongiorno-Borbone, A J Levine, E Candi, A D'Alessandro, L Zolla, A Finazzi ...

mehr

31.01.2013 | S Cagnol; N Rivard, Oncogene, 2013

Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition Oncogene 32, 564 (31 January 2013). doi:10.1038/onc.2012.88 Authors: S ...

mehr

31.01.2013 | A Chaves-Pérez; B Mack; D Maetzel; H Kremling; C Eggert; U Harréus; O Gires, Oncogene, 2013

EpCAM regulates cell cycle progression via control of cyclin D1 expression Oncogene 32, 641 (31 January 2013). doi:10.1038/onc.2012.75 Authors: A Chaves-Pérez, B Mack, D Maetzel, H Kremling, C Eggert, U Harréus & O Gires

mehr

24.01.2013 | Y-S Keum; H-G Kim; A M Bode; Y-J Surh; Z Dong, Oncogene, 2013

UVB-induced COX-2 expression requires histone H3 phosphorylation at Ser10 and Ser28 Oncogene 32, 444 (24 January 2013). doi:10.1038/onc.2012.71 Authors: Y-S Keum, H-G Kim, A M Bode, Y-J Surh & Z Dong

mehr

24.01.2013 | D Klokov; K Leskov; S Araki; Y Zou; E M Goetz; X Luo; D Willson; D A Boothman, Oncogene, 2013

Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect Oncogene 32, 479 (24 January 2013). doi:10.1038/onc.2012.64 Authors: D Klokov, K Leskov, S Araki, Y Zou, E M ...

mehr